Michiko Nakamura

Michiko Nakamura

Auto-generated profile, based on publicly available information

Michiko Nakamura

Department of Life Science Frontiers, Center for iPS Cell Research and Application, Kyoto University; Kyoto, 606-8507, Japan

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 January 1993 in NIPPON SHOKUHIN KOGYO GAKKAISHI
Verified
Journal Article
Open access
FKFujiko Kawamura
Fujiko Kawamura
AMAkemi Mayuzumi
Akemi Mayuzumi
MNMichiko Nakamura
Michiko Nakamura
SKShoichi Koizumi
Shoichi Koizumi
TKToshiaki Kimura
Toshiaki Kimura
TNTsuguaki Nishiya
Tsuguaki Nishiya

11 April 2025 in Science Advances
Verified
Journal Article
Open access
COChikako Okubo
Chikako Okubo
MNMichiko Nakamura
Michiko Nakamura
MSMasae Sato
Masae Sato
YSYuichi Shichino
Yuichi Shichino
MMMari Mito
Mari Mito
KTKazutoshi Takahashi
Kazutoshi Takahashi
Although pluripotent stem cell (PSC) properties, such as differentiation and infinite proliferation, have been well documented within the frameworks of transcription factor networks, epigenomes, and signal transduction, they remain unclear and fragmented. Directing attention toward translational regulation as a bridge between these events can yield additional insights into previously unexplained mechanisms. Our functional CRISPR interference screen–based approach revealed that EIF3D, a translation initiation factor, is crucial for maintaining primed pluripotency. Loss of EIF3D disrupted the balance of pluripotency-associated signaling pathways, thereby compromising primed pluripotency. Moreover, EIF3D ensured robust proliferation by controlling the translation of various p53 regulators, which maintain low p53 activity in the undifferentiated state. In this way, EIF3D-mediated translation contributes to tuning the homeostasis of the primed pluripotency networks, ensuring the maintenance of an undifferentiated state with high proliferative potential. This study provides further insights into the translation network in maintaining pluripotency.

14 May 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
LNLu Ni
Lu Ni
TMTakuya Murakami
Takuya Murakami
SSSatoshi Suzuki
Satoshi Suzuki
MHMari Hamao
Mari Hamao
MNMichiko Nakamura
Michiko Nakamura
KTKazutoshi Takahashi
Kazutoshi Takahashi
Advances in transcriptome profiling have revealed transcriptomic differences across different cellular states. However, functional interpretation requires precise perturbation tools and experimental frameworks. This study benchmarked two widely used modalities: CRISPR interference (CRISPRi) and Cas13d/CasRx. A standardized workflow was established to generate human pluripotent stem cells (PSCs) with inducible ZIM3-dCas9 or CasRx expression. The cell lines were subjected to flow cytometry, copy number, and immunocytochemical analyses. The knockdown performance was validated via robust OCT4 suppression and the expected downstream effects on pluripotency genes. Time-course measurements indicated that CRISPRi produced faster and stronger repression but slower recovery after inducer withdrawal. In contrast, CasRx yielded slower and typically weaker knockdown with rapid reversibility. Furthermore, a key limitation of CRISPRi was demonstrated using the ATF5 - NUP62 locus, wherein CRISPRi could co-repress genes with overlapping promoter regions. In contrast, CasRx avoids these limitations and supports isoform-resolved targeting of circular and alternatively spliced transcripts, albeit with variable efficiency. These results provide practical guidance for selecting complementary knockdown tools to improve the interpretability of transcriptomic function studies. MOTIVATION: Advances in transcriptome profiling have enabled the detection of subtle cell type-specific differences. However, mechanistic interpretation still depends on perturbation tools that can modulate transcripts with high precision and efficiency. Recent CRISPR-based modalities, CRISPRi and Cas13/CasRx, function as robust and orthogonal methods to achieve the knockdown of specific gene targets. However, a standardized approach for cell line preparation and comparative studies on their relative performances and limitations remains unclear. Consequently, this study presents a standardized workflow for generating cell lines that support high-efficiency knockdown using CRISPRi and CasRx. Moreover, it compares the trade-offs in potency, reversibility, and isoform resolution, along with a practical overview of method-specific pitfalls to guide tool selection and data interpretation in future studies. HIGHLIGHTS: Doxycycline-inducible AAVS1 knock-in human PSC platforms for CRISPRi (ZIM3-dCas9) and CasRx (RfxCas13d) were generated to enable standardized RNA perturbation experiments. The prepared cell lines demonstrated strong OCT4 knockdown, with expected downstream effects on the expression of another pluripotency gene, NANOG . A comparison of knockdown characteristics and their reversibility revealed rapid and sustained repression with CRISPRi, whereas slow but rapid recovery was observed with CasRx. A CRISPRi-specific off-target effect arising from TSS proximity/overlap ( ATF5 - NUP62 ) was identified, whereas CasRx achieved ATF5 knockdown without collateral repression of the neighboring NUP62 gene. CasRx enables isoform-resolved knockdown of structural isoforms (circHIPK3 vs. linear HIPK3 mRNA) and splice isoforms (RAB6A-iso1 vs. RAB6A-iso2).

13 October 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
KTKazutoshi Takahashi
Kazutoshi Takahashi
COChikako Okubo
Chikako Okubo
MNMichiko Nakamura
Michiko Nakamura
MIMio Iwasaki
Mio Iwasaki
YKYuka Kawahara
Yuka Kawahara
SYShinya Yamanaka
Shinya Yamanaka
Summary: Xeno-free culture systems have expanded the clinical and industrial application of human pluripotent stem cells (PSCs). However, yet some problems, such as the reproducibility among the experiments, remain. Here we describe an improved method for the subculture of human PSCs. The revised method significantly enhanced the viability of human PSCs by lowering DNA damage and apoptosis, resulting in more efficient and reproducible downstream applications such as gene editing, gene delivery, and directed differentiation. Furthermore, the method did not alter PSC characteristics after long-term culture and attenuated the growth advantage of abnormal subpopulations. This robust passaging method minimizes experimental error and reduces the rate of PSCs failing quality control of human PSC research and application. Highlights: The revised passaging method significantly increases the viability of human PSCs. The method triggers less DNA damage and apoptosis signals compared to the conventional method. The stress-reduced method improves the results of downstream applications. The method does not alter PSC characters and attenuates the overgrowth of abnormal subpopulations.

10 February 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
COChikako Okubo
Chikako Okubo
MNMichiko Nakamura
Michiko Nakamura
MSMasae Sato
Masae Sato
YSYuichi Shichino
Yuichi Shichino
MMMari Mito
Mari Mito
KTKazutoshi Takahashi
Kazutoshi Takahashi
Pluripotent stem cell (PSC) identities, such as differentiation and infinite proliferation, have long been understood within the frameworks of transcription factor networks, epigenomes, and signal transduction, yet remain unclear and fragmented. Directing attention toward translational regulation, as a bridge between these events, promises to yield new insights into previously unexplained mechanisms. Our functional CRISPR interference screening-based approach revealed that EIF3D maintains primed pluripotency through selective translational regulation. The loss of EIF3D disrupts the balance of pluripotency-associated signaling pathways, impairing primed pluripotency. Moreover, we discovered that EIF3D ensures robust proliferation by controlling the translation of various p53 regulators, which maintain low p53 activity in the undifferentiated state. In this way, selective translation by EIF3D tunes the homeostasis of the primed pluripotency networks, ensuring the maintenance of an undifferentiated state with high proliferative potential. Therefore, this study establishes a paradigm for selective translational regulation as a defining feature of primed PSC identity.